Abstract
Heart failure (HF) is associated with a high burden of mortality and morbidity, reduced quality of life, and increasing healthcare costs [1, 2]. HF is largel y a disease of old age, and it is becoming increasingly prevalent with the gradual aging of the global population [3]. HF is a complex syndrome in which abnormal heart function results in, or increases the subsequent risk of clinical symptoms and signs of low cardiac output and/or pulmonary and systemic congestion [4].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dargie HJ, McMurray JJ (1994) Diagnosis and management of heart failure. BMJ 308:321–328
Stewart S, MacIntyre K, Hole DJ et al (2001) More “malignant” than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3:315–322
American Heart Association (2005) Heart disease and stroke statistics: 2005 update. American Heart Association, Dallas
Johansen H, Strauss B, Arnold JM et al (2003) On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 19:430–435
Arnold JM, Liu P, Demers C et al (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22:23–45
Hunt SA, Abraham WT, Chin MH et al (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in adult — summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Endorsed by the Heart Rhythm Society. Circulation 112:1825–1852
Swedberg K, Cleland J, Dargie H et al (2005) ESC guidelines: guidelines for the diagnosis and treatment of chronic heart failure — executive summary (update 2005). The Task Force for the diagnosis and treatment of chronic heart failure of European Society of Cardiology. Eur Heart J 26:1115–1140
Cleland JG, Khand A, Cklark A (2001) The heart failure epidemic: exactly how big is it? Eur Heart J 22:623–626
Cleland JG, Gemmell I, Khand A et al (1999) Is prognosis of heart failure improving? Eur J Heart Fail 1:229–241
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction and clinical evidence of heart failure. Lancet 342:669–677
Merit HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001–2007
Granger CB, McMurray JJ, Yusuf S et al; CHARM Investigators and Committee (2003) Effect of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin converting enzyme inhibitors: the CHARM alternative trial. Lancet 362:772–776
Pitt B, Zannand F, Remme WJ et al; Randomized Aldactone Evaluation Study Investigators (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717
McAlister FA, Stewart S, Ferrua S, McMurray JJ (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for admissions: a systematic review of randomized trials. J Am Coll Cardiol 44:810–819
Moss AJ, Zareba W, Hall WJ et al; Multicentre Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Bardy GH, Lee KL, Mark DB et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med352:225–237
McAlister FA, EzeKowitz JA, Wiebe N et al (2004) Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Inter Med 141:381–390
Bristow MR, Saxon LA, Boehmer J et al; Comparison of Medical therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators (2004) Cardiac resynchronization therapy with and without an implantable defibrillator in advance chronic heart failure. N Engl J Med 350:2140–2150
Cleland JG, Daubert JC, Erdmann E et al; Cardiac Resynchronization Heart Failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549
Arnold JM, Howlett JG, Dorian P et al (2007) Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 23:21–45
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this paper
Cite this paper
Crystal, E., Calton, R. (2007). Heart-Failure Management: Focus on Heart-Failure Practice Guidelines. In: Gulizia, M.M. (eds) Current News in Cardiology. Springer, Milano. https://doi.org/10.1007/978-88-470-0636-2_14
Download citation
DOI: https://doi.org/10.1007/978-88-470-0636-2_14
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0635-5
Online ISBN: 978-88-470-0636-2
eBook Packages: MedicineMedicine (R0)